1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Tay-Sachs Disease Global Clinical Trials Review, H1, 2015

Tay-Sachs Disease Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 56 pages

Tay-Sachs Disease Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Tay-Sachs Disease Global Clinical Trials Review, H1, 2015" provides data on the Tay-Sachs Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tay-Sachs Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tay-Sachs Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Tay-Sachs Disease Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 5
Tay-Sachs Disease 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Tay-Sachs Disease to Genetic Disorders Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Unaccomplished Trials of Tay-Sachs Disease 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Tay-Sachs Disease Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Nuo Therapeutics, Inc. 24
Clinical Trial Overview of Nuo Therapeutics, Inc. 24
Natera, Inc. 25
Clinical Trial Overview of Natera, Inc. 25
ExSAR Corporation 26
Clinical Trial Overview of ExSAR Corporation 26
Clinical Trial Overview of Top Institutes / Government 27
Children's Research Institute 27
Clinical Trial Overview of Children's Research Institute 27
Masonic Cancer Center 28
Clinical Trial Overview of Masonic Cancer Center 28
Cambridge University Hospitals NHS Foundation Trust 29
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 29
The Hospital for Sick Children 30
Clinical Trial Overview of The Hospital for Sick Children 30
University of Louisville 31
Clinical Trial Overview of University of Louisville 31
University of Minnesota 32
Clinical Trial Overview of University of Minnesota 32
Duke University 33
Clinical Trial Overview of Duke University 33
Five Key Clinical Profiles 34
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 56

List of Tables

Tay-Sachs Disease Therapeutics, Global, Clinical Trials by Region, 2015* 6
Tay-Sachs Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Tay-Sachs Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Tay-Sachs Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* 9
Tay-Sachs Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Proportion of Tay-Sachs Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 11
Tay-Sachs Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 12
Tay-Sachs Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13
Tay-Sachs Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 14
Tay-Sachs Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 15
Tay-Sachs Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 16
Tay-Sachs Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 17
Tay-Sachs Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 18
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Tay-Sachs Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 20
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Nuo Therapeutics, Inc., 2015* 24
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Natera, Inc., 2015* 25
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by ExSAR Corporation, 2015* 26
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Research Institute, 2015* 27
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2015* 28
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015* 29
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2015* 30
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2015* 31
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2015* 32
Tay-Sachs Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 33

List of Figures

Tay-Sachs Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Tay-Sachs Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Tay-Sachs Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Tay-Sachs Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10
Proportion of Tay-Sachs Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 11
Tay-Sachs Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 12
Tay-Sachs Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13
Tay-Sachs Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 14
Tay-Sachs Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 15
Tay-Sachs Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 16
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Tay-Sachs Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 20
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Tay-Sachs Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
GlobalData Methodology 55

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

  • $ 5274
  • Industry report
  • September 2016
  • by Industry ARC

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.